AGENO, WALTER
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 7.225
NA - Nord America 4.524
EU - Europa 4.429
AF - Africa 3.145
SA - Sud America 2.920
OC - Oceania 337
Continente sconosciuto - Info sul continente non disponibili 168
Totale 22.748
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.873
BR - Brasile 1.719
SG - Singapore 1.526
HK - Hong Kong 1.152
VN - Vietnam 734
CN - Cina 715
PL - Polonia 711
IT - Italia 383
AR - Argentina 242
NL - Olanda 219
KR - Corea 159
TR - Turchia 156
EC - Ecuador 151
RU - Federazione Russa 150
ID - Indonesia 144
MX - Messico 142
DE - Germania 138
ZA - Sudafrica 125
FR - Francia 122
CO - Colombia 118
IQ - Iraq 118
SE - Svezia 118
PY - Paraguay 117
CL - Cile 114
IN - India 114
AL - Albania 112
AO - Angola 111
LB - Libano 106
UY - Uruguay 104
MA - Marocco 103
UZ - Uzbekistan 103
BJ - Benin 102
HN - Honduras 102
JO - Giordania 102
FI - Finlandia 101
AM - Armenia 100
DO - Repubblica Dominicana 100
VE - Venezuela 98
BA - Bosnia-Erzegovina 97
CZ - Repubblica Ceca 97
GT - Guatemala 97
DZ - Algeria 96
DK - Danimarca 95
RS - Serbia 95
SN - Senegal 95
AZ - Azerbaigian 94
CW - ???statistics.table.value.countryCode.CW??? 94
PA - Panama 94
AE - Emirati Arabi Uniti 93
AT - Austria 93
BF - Burkina Faso 92
KE - Kenya 92
PS - Palestinian Territory 91
BZ - Belize 90
ES - Italia 90
IE - Irlanda 90
PK - Pakistan 90
EG - Egitto 89
GA - Gabon 89
GF - Guiana Francese 89
JP - Giappone 89
KH - Cambogia 89
GR - Grecia 88
IL - Israele 88
ME - Montenegro 88
NI - Nicaragua 88
LV - Lettonia 87
ML - Mali 87
PH - Filippine 87
BE - Belgio 86
JM - Giamaica 86
PE - Perù 86
RO - Romania 85
UA - Ucraina 85
UG - Uganda 85
CV - Capo Verde 84
GE - Georgia 84
HR - Croazia 84
LA - Repubblica Popolare Democratica del Laos 84
BW - Botswana 83
CI - Costa d'Avorio 83
KG - Kirghizistan 83
KZ - Kazakistan 83
MR - Mauritania 83
BO - Bolivia 82
MY - Malesia 82
ZW - Zimbabwe 82
BS - Bahamas 81
HU - Ungheria 81
TT - Trinidad e Tobago 81
AU - Australia 80
BY - Bielorussia 80
CH - Svizzera 80
LY - Libia 80
IR - Iran 79
LC - Santa Lucia 79
MN - Mongolia 79
PT - Portogallo 79
SA - Arabia Saudita 79
SI - Slovenia 79
Totale 18.984
Salva come PNG Salva come JPEG
Città #
Hong Kong 1.078
Singapore 703
Bytom 617
Hefei 324
Ashburn 317
Ho Chi Minh City 297
Chicago 241
Los Angeles 229
Fairfield 184
Redondo Beach 159
Beijing 152
Buffalo 135
São Paulo 129
Hanoi 126
Chandler 100
Amman 95
Dakar 92
Salt Lake City 92
Tashkent 92
Baku 91
Cotonou 90
Seoul 90
Libreville 84
Luanda 84
Managua 84
Kampala 83
Yerevan 83
Nairobi 82
Phnom Penh 82
Bamako 81
Montevideo 81
Panama City 80
Abidjan 77
Nassau 77
Nouakchott 77
Ulan Bator 77
Castries 75
Munich 75
Vientiane 75
Woodbridge 75
Harare 73
Kigali 73
Podgorica 72
Bishkek 70
Cambridge 70
Ouagadougou 70
Seattle 70
Willemstad 69
Vienna 67
Dushanbe 66
Cayenne 65
Lusaka 64
Praia 64
Riga 64
Accra 63
Andorra la Vella 63
Antananarivo 63
Bridgetown 63
Conakry 63
Dili 62
Tbilisi 62
Houston 61
Noumea 61
Tirana 60
Wilmington 60
Guatemala City 59
Kingston 59
Kingstown 59
Minsk 58
Dublin 56
Addis Ababa 55
Havana 55
Zagreb 55
Belgrade 54
Luxembourg 53
Gaborone 52
Reykjavik 52
Lima 51
Quito 51
San José 51
Tallinn 51
Dar es Salaam 50
Rio de Janeiro 50
Tripoli 49
Guayaquil 48
Lilongwe 48
Niamey 48
Pristina 48
Athens 47
Auckland 46
Baghdad 46
Kinshasa 45
Papeete 44
San Pedro Sula 44
Istanbul 43
Port Moresby 43
Sofia 43
Chisinau 41
Maputo 41
Ann Arbor 40
Totale 10.238
Salva come PNG Salva come JPEG
Nome #
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 268
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: the Multicenter Italian CORIST Study 242
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 209
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 199
Disentangling the association of hydroxychloroquine treatment with mortality in covid-19 hospitalized patients through hierarchical clustering 180
Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study 175
Impact of residual pulmonary obstruction on the long-term outcome of patients with pulmonary embolism 174
The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism 169
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study 167
D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study 150
The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2 145
Long-term outcomes of patients with cerebral vein thrombosis: A multicenter study 142
Association between the metabolic syndrome, its individual components, and unprovoked venous thromboembolism: results of a patient-level meta-analysis. 134
A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery: Surgery After Stenting 2 126
Anticoagulation resumption after intracranial hemorrhage in patients treated with VKA and DOACs 120
Patients with antiphospholipid syndrome and a first venous or arterial thrombotic event: Clinical characteristics, antibody profiles and estimate of the risk of recurrence 119
D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study 118
Rates of venous thromboembolism and use of thromboprophylaxis after major orthopedic surgery in patients with congenital hemophilia A or B: a systematic review 117
Lack of efficacy of direct oral anticoagulants compared to warfarin in antiphospholipid antibody syndrome 113
Inappropriate Underdosing of Direct Oral Anticoagulants in Atrial Fibrillation Patients: Results from the START2-AF Registry 110
D-dimer and risk of venous thromboembolism recurrence: Comparison of two studies with similar designs but different laboratory and clinical results 108
Measuring the crowding of emergency departments: an assessment of the NEDOCS in Lombardy, Italy, and the development of a new objective indicator based on the waiting time for the first clinical assessment 106
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (Internal and Emergency Medicine, (2018), 13, 5, (651-660), 10.1007/s11739-018-1835-9) 105
Description of the clinical and radiological characteristics of pulmonary embolism in COVID-19 vs non–COVID-19 patients: a multicentric cross-sectional study over a 24-month perspective 101
Can the Charlson comorbidity index help to guide DOAC dosing in patients with atrial fibrillation and improve the efficacy and safety of treatment? A subanalysis of the MAS study 98
Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis 93
Second consensus document on diagnosis and management of acute deep vein thrombosis: updated document elaborated by the ESC Working Group on aorta and peripheral vascular diseases and the ESC Working Group on pulmonary circulation and right ventricular function 93
Survival and Quality of Life after Early Discharge in Low-Risk Pulmonary Embolism 91
Low in-hospital mortality rate in patients with COVID-19 receiving thromboprophylaxis: data from the multicentre observational START-COVID Register 90
Anticoagulation in Patients with Isolated Distal Deep Vein Thrombosis: Bringing the Puzzle Together 87
Changes in the landscape of anticoagulation: a focus on direct oral anticoagulants 86
ANMCO Position Paper: Long-term follow-up of patients with pulmonary thromboembolism 84
ANMCO Position paper: Recommendations for the follow-up of patients with pulmonary thromboembolism 81
Reperfusion therapies in patients with acute ischaemic stroke and atrial fibrillation: data on safety and effectiveness from a multi-centre cohort study 80
Early Time Courses of Recurrent Venous Thromboembolism and Bleeding during Apixaban or Dalteparin Therapy for Patients with Cancer 79
Direct Oral Anticoagulants for Pulmonary Embolism 79
Cardiac power output is associated with cardiovascular related mortality in the ICU in post-cardiac arrest patients 79
Risk assessment tools for bleeding in patients with unprovoked venous thromboembolism: an analysis of the PLATO-VTE study 78
Catheter-related deep vein thrombosis: Where are we at and where are we going? Updates and ongoing unmet clinical needs 78
Ultrasound elastography is useful to distinguish acute and chronic deep vein thrombosis 78
Anticoagulant treatment for pediatric splanchnic vein thrombosis: a systematic review and meta-analysis 77
Investigational drugs for ischemic stroke: what’s in the clinical development pipeline for acute phase and prevention? 77
Incidence of chronic thromboembolic pulmonary hypertention after a first episode of pulmonary embolism 77
Venous thromboembolism in Asia and worldwide: Emerging insights from GARFIELD-VTE 76
The effect of DOAC-Stop® on several oral and parenteral anticoagulants 76
Hypoalbuminaemia and heart failure: A practical review of current evidence 75
Relationship between regulatory T cells subsets and lipid profile in dyslipidemic patients: A longitudinal study during atorvastatin treatment 75
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism 74
Six-week low-molecular-weight heparin versus 12-week warfarin for calf deep vein thrombosis: A randomized, prospective, open-label study 74
Treatment of Superficial Vein Thrombosis: Recent Advances, Unmet Needs and Future Directions 73
The metabolic syndrome and the risk of venous thrombosis: A case-control study 73
How to treat isolated distal deep vein thrombosis 72
Common Practice in the Treatment of Superficial Vein Thrombosis Involving the Sapheno-Femoral Junction: Results from a National Survey of the Italian Society of Angiology and Vascular Medicine (SIAPAV) 72
How to manage splanchnic vein thrombosis in patients with liver disease 72
In vitro effects of Apixaban on 5 different cancer cell lines 72
The Clinical Impact of the Pulmonary Embolism Severity Index on the Length of Hospital Stay of Patients with Pulmonary Embolism: A Randomized Controlled Trial 71
The influence of anemia on clinical outcomes in venous thromboembolism: Results from GARFIELD-VTE 71
Platelet RNA sequencing for cancer screening in patients with unprovoked venous thromboembolism: a prospective cohort study 71
PROPOSAL FOR THE INCLUSION OF LOW MOLECULAR WEIGHT HEPARINS FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM IN HOSPITALIZED PATIENTS IN THE WHO MODEL LIST OF ESSENTIAL MEDICINES 70
Safety and efficacy of anticoagulant treatment in patients with ovarian vein thrombosis: a systematic review and meta-analysis of observational studies 69
Novel horizons in anticoagulation: the emerging role of factor XI inhibitors across different settings 69
Algorithm for rapid exclusion of clinically relevant plasma levels of DOACs in patients using the DOAC Dipstick. An expert consensus paper 69
Long-term left ventricular thrombosis resolution in patients receiving vitamin k antagonists: a multicenter observational study 69
More early bleeds associated with high baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study 69
Timing of anticoagulation for the management of portal vein thrombosis in liver cirrhosis 69
Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis 69
Risk of Bleeding in Liver Cirrhosis Receiving Direct Oral Anticoagulants: A Systematic Review and Meta-analysis 68
Statins under-treatment and mortality in patients with atrial fibrillation. Insights from the nationwide START registry 68
Enoxaparin for symptomatic COVID-19 managed in the ambulatory setting: An individual patient level analysis of the OVID and ETHIC trials 68
Coming soon to a pharmacy near you? FXI and FXII inhibitors to prevent or treat thromboembolism 68
The legacy of Edwards and Steptoe and the windy roads of Assisted Reproduction: where do we stand with Venous Thromboembolism? 68
Risk Factors for Intracerebral Hemorrhage in Patients with Atrial Fibrillation on Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention 67
Sex-related differences in non-ischemic myocardial injury in the emergency department: A real-world perspective 66
Splanchnic vein thrombosis-related mortality in the Veneto region (Italy), 2008-2019: Retrospective analysis of epidemiological data 66
Prognostic role of neutrophils to lymphocytes ratio in patients with acute pulmonary embolism: a systematic review and meta-analysis of the literature 66
Inhibition of thrombin-activatable fibrinolysis inhibitor via DS-1040 to accelerate clot lysis in patients with acute pulmonary embolism: a randomized phase 1b study 65
Impact of the 2023 ACR/EULAR Classification Criteria on START2 Antiphospholipid Registry 64
Factor XI/XIa inhibitors for splanchnic vein thrombosis associated with liver cirrhosis: Is there any potential role? 64
Sex-related characteristics of cerebral vein thrombosis: A secondary analysis of a multicenter international cohort study 63
Intracranial bleeding risk after minor traumatic brain injury in patients on antithrombotic drugs 63
Pharmacotherapeutic management of venous thromboembolism during pregnancy and cesarean section 62
Aktuelles zu Inzidenz, Risikofaktoren und Behandlung von venösen Thrombosen an ungewöhnlichen Stellen 62
Rapid salivary test suitable for a mass screening program to detect SARS-CoV-2: a diagnostic accuracy study 60
Risk of Coronary Artery Disease in Patients with Liver Cirrhosis: A Systematic Review and Meta-analysis 60
The use of reduced DOAC doses in atrial fibrillation patients does not always lead to good anticoagulation levels and avoid adverse events 60
International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER) 60
The Link Between Venous and Arterial Thrombosis: Is There a Role for Endothelial Dysfunction? 60
Chronobiologic Aspects of Venous Thromboembolism 58
Predictive value of venous thromboembolism (VTE)-BLEED to predict major bleeding and other adverse events in a practice-based cohort of patients with VTE: results of the XALIA study 58
D-dimer levels during and after anticoagulation withdrawal in patients with venous thromboembolism treated with non-Vitamin K anticoagulants 58
Management and Outcomes of Isolated Distal Deep Vein Thromboses: A Questionable Trend toward Long-Lasting Anticoagulation Treatment. Results from the START-Register 58
Guidelines and guidance: what is the path forward for the ISTH? 57
Cause of death and predictors of all-cause mortality in anticoagulated patients with nonvalvular atrial fibrillation: Data from ROCKET AF 57
Causes and Risk Factors of Cerebral Ischemic Events in Patients with Atrial Fibrillation Treated with Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention: The RENo Study 57
Long-Term Outcome of Splanchnic Vein Thrombosis in Cirrhosis 56
Rivaroxaban treatment for six weeks versus three months in patients with symptomatic isolated distal deep vein thrombosis: Randomised controlled trial 56
Introduction of SARS-CoV-2 variant of concern 20h/501Y.V2 (B.1.351) from Malawi to Italy 55
Current management of cancer-associated venous thromboembolism in patients with thrombocytopenia: a retrospective cohort study 55
Applying EBM in haematological practice 54
Breadth of complications of long-term oral anticoagulant care 53
Totale 8.912
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.161
article - articoli 43.177
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 120
patent - brevetti 0
selected - selezionate 0
volume - volumi 217
Totale 87.675
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021148 0 0 0 0 1 4 1 21 36 20 21 44
2021/2022323 35 4 59 26 31 15 12 24 40 9 18 50
2022/2023172 35 26 3 20 21 16 2 18 12 1 18 0
2023/2024152 3 12 13 10 11 29 13 36 6 2 13 4
2024/20253.936 7 47 52 20 42 31 28 35 56 643 1.140 1.835
2025/202618.247 697 1.966 6.981 7.347 1.256 0 0 0 0 0 0 0
Totale 23.281